	Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival. ESMO Open Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching PA, Bardia A, Chia S, Im SA, Martin M, Xu B, Barrios CH, Untch M, Moroose R, Hurvitz SA, Hortobagyi GN, Slamon DJ, Visco F, Spera G, Zarate JP, Halligan D, Li Z, Loi S. PMID: 41320342 [PubMed - indexed for MEDLINE]
	Volatile organic compound signatures in breast cancer: A pilot study on cell-based detection. Clin Chim Acta Tenorio-Salazar AJ, Orduña-Medina FM, Mizaikoff B, Mitrovics J, de León-Martínez LD, Alcántara-Quintana LE. PMID: 41319908 [PubMed - as supplied by publisher]
	Progress in nanotechnology-based strategies to enhance tamoxifen therapy for breast cancer management. Pathol Res Pract Mangu K, Gandhi AN, Rizwanullah M. PMID: 41319556 [PubMed - as supplied by publisher]
	The impact of social determinants of health on mental and behavioral health trajectories of breast cancer survivors: A longitudinal cohort study. Eur J Oncol Nurs Franco-Rocha OY, Fuentes-Balderrama J, Sun B, Smits JAJ, Magnuson A, Kesler SR, Van Dyk K, Moore RC, Henneghan AM. PMID: 41319526 [PubMed - as supplied by publisher]
	Phase Separation of PHLDB2 Drives EMT and Tumor Progression in Triple-Negative Breast Cancer. Cancer Med Zhang M, Liang C, Chen T, Shi X, Hao J. PMID: 41319208 [PubMed - indexed for MEDLINE]
	Leveraging HIV prevention programs for breast cancer interventions: A survey of women stakeholders in the informal work sector in Nigeria. Womens Health (Lond) Oluwasanu M, Ibraheem A, Wang Y, Odukoya OA, Ogundipe RO, Oluwasanu AO, Adejumo P, Oladepo O, Huo D, Olopade OI. PMID: 41319006 [PubMed - indexed for MEDLINE]
	Preliminary Outcomes of a Culturally Adapted Fear of Recurrence Therapy (FORT) for Turkish Breast Cancer Survivors: A Randomized Controlled Trial. Psychooncology Eyrenci A, Ertuna L, Bahçivan O. PMID: 41318944 [PubMed - indexed for MEDLINE]
	ASCL2 contributes to clinical assessments of breast cancer and mediates tumor progression via the interaction with CLDN3. Sci Rep Yin Y, Meng Q, Liu X, Xu F, Li Y, Han X, Guo Q, Lv Y. PMID: 41318809 [PubMed - as supplied by publisher]
	A novel four-serum marker model for early detection and therapeutic monitoring of breast cancer. Sci Rep Chen S, Zeng J, Gong K, Liu Y, Long S, Han L, Luo D. PMID: 41318767 [PubMed - as supplied by publisher]
	Pregnancy-associated breast cancer: gestational weight gain impact and nomogram validation. BMC Cancer Liu C, Wang R, Wang S, Liu S, Wu X, Zheng W, Li S, Yu T, Hao J, Zhang L. PMID: 41318535 [PubMed - as supplied by publisher]
	Is the serratus posterior superior intercostal plane block a viable alternative to the erector spinae plane block for postoperative analgesia in breast surgery? A prospective, randomized trial. BMC Anesthesiol Ar, Zengin M, , Küçük O, Güngördü E, Özgüner Y, Alagöz A, Ergil J. PMID: 41318393 [PubMed - as supplied by publisher]
	Mapping Knowledge Landscapes and Emerging Trends in Contrast-Enhanced Ultrasound for Breast Cancer: A Bibliometric and Visualization Analysis. Ultrasound Med Biol Wang C, Hu Z, Li X, Ding Y, Zhang C. PMID: 41318251 [PubMed - as supplied by publisher]
	Efficacy and Safety of Oral 5-FU Derivatives After Progression of HR(+)/HER2(-) Metastatic Breast Cancer on CDK4/6 Inhibitor. Anticancer Res Koi Y, Tajiri W, Kawasaki J, Akiyoshi S, Ijichi H, Nakamura Y, Koga C, Tokunaga E. PMID: 41318158 [PubMed - indexed for MEDLINE]
	Effect of Tissue Sample Type on The Evaluation of PD-L1 (SP142) Expression in Breast Cancer. Anticancer Res Usui T, Shimoda M, Abe K, Masunaga N, Tsukabe M, Yoshinami T, Sota Y, Miyake T, Tanei T, Shimazu K. PMID: 41318153 [PubMed - indexed for MEDLINE]
	Leveraging Genome-wide Association Studies to Identify Pathogenic Variants for Breast Cancer Among Multiple Continents. Anticancer Res Admanegara PPS, Yulianti R, Rahmawati D, Widiastuti S, Adikusuma W, Wirashada BC, Amukti DP, Darmawi D, Rispawati BH, Iskandar B, Chong R, Ates I, Irham LM. PMID: 41318116 [PubMed - indexed for MEDLINE]
	Prediction of lung metastasis in breast cancer patients using machine learning classifiers. J Mol Diagn Nguyen TD, Nguyen Thi QM, Van Nguyen T, Bui TP, Nguyen Thi KN, Nguyen MN. PMID: 41318062 [PubMed - as supplied by publisher]
	Baseline characteristics predicting lower return rates of missing patient-reported quality of life data over 5â€¯years: evidence from the IMPORT HIGH and IMPORT LOW breast cancer radiotherapy trials. Radiother Oncol Ng S, Kirby AM, Kilburn LS, Griffin C, Sydenham M, Lloyd L, Kirwan CC, Jefford M, Syndikus I, Bliss JM, Coles CE. PMID: 41318001 [PubMed - as supplied by publisher]
	Multi-dimensional targeting of the tumor microenvironment to inhibit the invasion and metastasis of breast cancer. Pathol Res Pract Wang Y, Wang Q, Chang J, Chen Z, Qi C, Jiang X, Feng X. PMID: 41317713 [PubMed - as supplied by publisher]
	Post-mastectomy radiotherapy negatively impacts short-term patient-reported outcomes in patients with and without immediate breast reconstruction - a retrospective cohort study. Eur J Surg Oncol Zehnpfennig L, Maggi N, Levy J, Loesch JM, Kiblawi R, Frevert ML, Schwab FD, Haug MD, Kurzeder C, Weber WP, Heidinger M. PMID: 41317650 [PubMed - as supplied by publisher]
	Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study. Breast Bianco N, Valenza C, Milano M, Multinu R, Battaiotto E, Cavallone M, Malvezzi G, Trapani D, Della Vigna P, Bonomo G, Varano GM, Maiettini D, Pitoni MG, Sangalli C, Munzone E, Curigliano G, Colleoni MA, Orsi F. PMID: 41317597 [PubMed - as supplied by publisher]

Articles 1 - 20 / 212384

Page 1 of 10620



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy